Artepharm Global Corp.: Humanitarian Organization To Monitor Malaria Project

Main Category: Tropical Diseases
Also Included In: Infectious Diseases / Bacteria / Viruses
Article Date: 20 Jul 2010 - 5:00 PDT

email to a friend   printer friendly   opinions  

Artepharm Global Corp. (the "Company") (OTCBB:ARGC) is pleased to announce that Doctors Without Borders/Médecins Sans Frontières (MSF) will be involved with the malaria eradication project on the Comoros Islands led by Artepharm Co.

The original project by Artepharm Co. was the subject of an 18-minute documentary by the TV news show Dateline (Australia) in March 2009. The documentary showcased Artepharm Co.'s work in eradicating malaria on the island of Mohéli, in the Comoros Islands off the east coast of Africa. Just months after the Mohéli project was launched in November 2007, the island's malaria infection rate dropped rapidly from 22% to 2%. Within the year leading up to this documentary, there were no deaths attributed to malaria. The full documentary can be viewed here.

The current project, financed in part by the Qatar Foundation (see our press release dated July 7th, 2010), will target the entire population of the Comoros Islands. The size and scope of this project is roughly 25 times that of the original project on Mohéli, covering over 800,000 people. The success of a project of this nature will further solidify the effectiveness of the Company's anti-malarial drug, Artequick©.

The Company is very pleased to report that Doctors Without Borders/Médecins Sans Frontières (MSF), a Nobel Peace Prize winning humanitarian organization, will monitor and analyze the results the current project. Today, MSF provides aid in nearly 60 countries to people whose survival is threatened by violence, neglect, or catastrophe, primarily due to armed conflict, epidemics, malnutrition, exclusion from healthcare, or natural disasters. MSF provides independent, impartial assistance to those most in need. MSF reserves the right to speak out to bring attention to neglected crises, to challenge inadequacies or abuse of the aid system, and to advocate for improved medical treatments and protocols.

Source:
Artepharm Global Corp.

• Additional
• References
• Citations